| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.06 | 0.3 |